BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35892668)

  • 1. Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients.
    Versteylen MO; Brons M; Teske AJ; Oerlemans MIFJ
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.
    Palmer C; Truong VT; Slivnick JA; Wolking S; Coleman P; Mazur W; Zareba KM
    Sci Rep; 2022 Jan; 12(1):140. PubMed ID: 34996915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
    Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
    Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis.
    Aimo A; Fabiani I; Giannoni A; Mandoli GE; Pastore MC; Vergaro G; Spini V; Chubuchny V; Pasanisi EM; Petersen C; Poggianti E; Taddei C; Castiglione V; Latrofa S; Panichella G; Sciaccaluga C; Georgiopoulos G; Passino C; Cameli M; Emdin M
    Eur Heart J Cardiovasc Imaging; 2022 Dec; 24(1):130-141. PubMed ID: 35292807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis.
    Singulane CC; Slivnick JA; Addetia K; Asch FM; Sarswat N; Soulat-Dufour L; Mor-Avi V; Lang RM
    J Am Soc Echocardiogr; 2022 Aug; 35(8):829-835.e1. PubMed ID: 35398489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial structure and function in cardiac amyloidosis.
    Nochioka K; Quarta CC; Claggett B; Roca GQ; Rapezzi C; Falk RH; Solomon SD
    Eur Heart J Cardiovasc Imaging; 2017 Oct; 18(10):1128-1137. PubMed ID: 28637305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
    Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
    J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-parametric speckle tracking analyses to characterize cardiac amyloidosis: a comparative study of systolic left ventricular longitudinal myocardial mechanics.
    Bogunovic N; Farr M; Pirl L; Piper C; Rudolph V; Roder F
    Heart Vessels; 2022 Sep; 37(9):1526-1540. PubMed ID: 35357543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis.
    Meucci MC; Lillo R; Mango F; Marsilia M; Iannaccone G; Tusa F; Luigetti M; Biagini E; Massetti M; Lanza GA; Lombardo A; Graziani F
    Int J Cardiol; 2024 May; 402():131891. PubMed ID: 38382852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis.
    Lindow T; Lindqvist P
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34201866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
    Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
    ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
    Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
    Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiogenic Shock Due to Atrial Arrhythmia as the Initial Presentation of Transthyretin Cardiac Amyloidosis.
    Schneider SM; Kochar K; Ruge M; Marek-Iannucci S; Datta T; Hajduczok A; Ullah W; Rajapreyar I; Brailovsky Y
    JACC Case Rep; 2022 Nov; 4(22):1490-1495. PubMed ID: 36444185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient.
    Vergaro G; Castiglione V; Poletti R; Buda G; Pucci A; Musetti V; Genovesi D; Aimo A; Passino C; Emdin M
    JACC Case Rep; 2021 Mar; 3(3):450-454. PubMed ID: 34317556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis.
    Xin Y; Hu W; Chen X; Hu J; Sun Y; Zhao Y
    Hellenic J Cardiol; 2019; 60(6):375-383. PubMed ID: 30742933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study.
    Liu XH; Shi JY; Zhang DD; Jia FW; Lin X; Zhu YL; Zhuang JL; Fang LG; Chen W
    BMC Cardiovasc Disord; 2022 Apr; 22(1):175. PubMed ID: 35428181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.